Branch Retinal Vein Occlusion after Messenger RNA-Based COVID-19 Vaccine

Two days after the second dose of the messenger RNA-based COVID-19 vaccine (BNT162b2), a healthy 38-year-old man developed branch retinal vein occlusion (BRVO) in his left eye (OS). His previous medical history was unremarkable and he was a nonsmoker. His blood pressure was 117/78 mm Hg. Blood exami...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugihara, Kazunobu, Kono, Michihiro, Tanito, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832183/
https://www.ncbi.nlm.nih.gov/pubmed/35221977
http://dx.doi.org/10.1159/000521838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832183/
https://www.ncbi.nlm.nih.gov/pubmed/35221977
http://dx.doi.org/10.1159/000521838

Ejemplares similares